LY364947 - CAS 396129-53-6
Catalog number:
Not Intended for Therapeutic Use. For research use only.
TGF-β Receptor
LY364947 is a selective inhibitor of TGF-β type-I receptor with potential anticancer activity. LY364947 inhibits TGF-β-dependent luciferase production in mink lung cells (p3TP lux) and growth in mouse fibroblasts (NIH 3T3).
Publictions citing BOC Sciences Products
  • >> More
LY364947; LY-364947; LY 364947; HTS 466284.
1.Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations.
Bansal SS1, Celia C, Ferrati S, Zabre E, Ferrari M, Palapattu G, Grattoni A. Curr Drug Targets. 2013 Aug;14(9):1061-9.
Combined use of gemcitabine (Gem) and LY-364947 (LY), a TGF-β1 receptor inhibitor, has shown promise for the treatment of fibrotic pancreatic cancer, by reducing collagen production and improving tumor drug penetration. The preparation and optimization of novel Gem and LY formulations, including co-encapsulation in liposomes, require a validated method for the simultaneous quantification of both drugs, a method that had yet to be developed. Here we demonstrate an RP-HPLC protocol for the simultaneous detection of Gem and LY at 266 and 228 nm with retention times of 3.37 and 11.34 mins, respectively. The method, which uses a C18 column and a KH2PO4 (10 mM)-methanol mobile phase, was validated for linearity, precision, accuracy, limits of detection, and robustness. Co-loaded liposomes with both Gem and LY (Gem/LY liposomes) were developed to investigate the protocol applicability to pharmacokinetic analysis and formulation characterization.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related TGF-β Receptor Products

LSKL, Inhibitor of Thrombospondin TSP-1

LSKL, Inhibitor of Thrombospondin (TSP-1), derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-β, thus prevents the p...

CAS 700874-72-2 Galunisertib

(CAS: 700874-72-2)

Galunisertib, also known as LY2157299, is a novel selective small molecule transforming growth factor beta receptor (TGF-βR) kinase inhibitor.LY2157299 inhibite...

CAS 909910-43-6 A83-01

(CAS: 909910-43-6)

CAS 446859-33-2 Repsox

(CAS: 446859-33-2)

Repsox is an inhibitor of the TGF-β type 1 activin like kinase receptor ALK5. At 25 μM, it can be used to induce stem cell pluripotency by replacing the reprogr...

CAS 396129-53-6 LY364947

(CAS: 396129-53-6)

LY364947 is a selective inhibitor of TGF-β type-I receptor with potential anticancer activity. LY364947 inhibits TGF-β-dependent luciferase production in mink l...

CAS 452342-67-5 GW788388

(CAS: 452342-67-5)

CAS 607737-87-1 A-77-01

(CAS: 607737-87-1)

A-77-01 is an inhibitor of TGF-β type I receptor superfamily activin-like kinase ALK5( IC50 =25nM).

(CAS: 1099644-42-4)

ITD-1 is an effective and highly selective TGF-β signaling inhibitor which could promote cardiomyocyte differentiation through degradation of the TGFBR2 so that...

CAS 627536-09-8 SD-208

(CAS: 627536-09-8)

SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, >100-fold selectivity over TGF-βRII.

CAS 1352608-82-2 EW-7197

(CAS: 1352608-82-2)

EW-7197 is a potent ALK5 inhibitor. EW-7197 showed potent in vivo anti-metastatic activity, indicating its potential for use as an anti-cancer therapy. EW-7197...

CAS 356559-20-1 SB525334

(CAS: 356559-20-1)

Chemical Structure

CAS 396129-53-6 LY364947

Quick Inquiry

Verification code

Featured Items